Journal article
Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
- Abstract:
-
BACKGROUND: Several randomized clinical trials in chronic myeloid leukemia (CML) have reported better patient survival with interferon alfa (IFN alpha) than with standard chemotherapeutic agents, such as busulfan or hydroxyurea. However, the size and persistence of this survival benefit is uncertain. Our aim was to assess these reliably, both overall and in particular patient subgroups. METHODS: We collaborated in a worldwide overview of all clinical trials in which patients with CML were ran...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Journal of the National Cancer Institute
- Volume:
- 89
- Issue:
- 21
- Pages:
- 1616-1620
- Publication date:
- 1997-11-01
- EISSN:
-
1460-2105
- ISSN:
-
0027-8874
- Source identifiers:
-
96029
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:96029
- UUID:
-
uuid:05d666d8-c6ea-4faf-b3bd-08b2cdcafa81
- Local pid:
- pubs:96029
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 1997
If you are the owner of this record, you can report an update to it here: Report update to this record